4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001689375-22-000050
President and CEO sold 14,590 shares at an average $15.02 ($219,119)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Doshi Dipal President and CEO | 2022-12-27 | Sale | −600 | $14.80 | $8,879 | 182,235 | D |
| Doshi Dipal President and CEO | 2022-12-27 | Sale | −9,069 | $15.04 | $136,383 | 173,166 | D |
| Doshi Dipal President and CEO | 2022-12-28 | Sale | −4,521 | $15.01 | $67,852 | 168,645 | D |
| Doshi Dipal President and CEO | 2022-12-29 | Sale | −400 | $15.01 | $6,005 | 168,245 | D |
| Open-market sales · 14,590 sh · avg $15.02 · $219,119 | |||||||
Loading xslF345X03/wf-form4_167235065224928.xml…